Cargando…

Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation

BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Yang, Liu, Qi, Liu, Li, Shu, Xiao-Rong, Su, Zi-Zhuo, Zhang, Hai-Feng, Nie, Ru-Qiong, Wang, Jing-Feng, Xie, Shuang-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072249/
https://www.ncbi.nlm.nih.gov/pubmed/27748329
http://dx.doi.org/10.4103/0366-6999.191744
Descripción
Sumario:BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on risk stratification of LA/LAA thrombus formation in patients with nonvalvular atrial fibrillation (NVAF). METHODS: This cross-sectional study enrolled 294 consecutive NVAF patients without prior anticoagulant and lipid-lowering therapies. LA/LAA thrombus was determined by transesophageal echocardiography. Risk assessment of LA/LAA thrombus was performed using the CHADS(2), CHA(2)DS(2)-VASc, MS, CHADS(2)-MS, and CHA(2)DS(2)-VASc-MS scores. Logistic regression analyses were performed to determine which factors were significantly related to LA/LAA thrombus. Odds ratio (OR) including 95% confidence interval was also calculated. The predictive powers of different scores for the risk of LA/LAA thrombus were represented by C-statistics and compared by receiver operating characteristic (ROC) analysis. RESULTS: LA/LAA thrombi were identified in 56 patients (19.0%). Logistic analysis showed that MS was the strongest risk factor for LA/LAA thrombus in NVAF patients (OR = 14.698, P < 0.001). ROC curve analyses revealed that the C-statistics of CHADS(2)-MS and CHA(2)DS(2)-VASc-MS was significantly higher than those of CHADS(2) and CHA(2)DS(2)-VASc scores (CHADS(2)-MS vs. CHADS(2), 0.807 vs. 0.726, P = 0.0019). Furthermore, MS was helpful for identifying individuals with a high risk of LA/LAA thrombus in the population with a low risk of stroke (CHADS(2) or CHA(2)DS(2)-VASc score = 0). CONCLUSIONS: MS is associated with LA/LAA thrombus risk in patients with NVAF. In addition to the CHADS(2) and CHA(2)DS(2)-VASc scores, the CHADS(2)-MS and CHA(2)DS(2)-VASc-MS scores provide additional information on stroke risk assessment.